-+ 0.00%
-+ 0.00%
-+ 0.00%

ATYR PHARMA PROVIDES REGULATORY AND CLINICAL UPDATE FOR EFZOFITIMOD IN PULMONARY SARCOIDOSIS FOLLOWING FDA TYPE C MEETING

Reuters·05/11/2026 20:01:00

Please log in to view news